Contact Hours: 1.5

Max CEU Credits: 0.15

Learning Objectives:

Upon completion of the chapter the reader will be able to:
1. Recognize differences between ulcers induced by Helicobacter pylori (HP) and nonsteroidal anti-inflammatory drugs (NSAIDs) in terms of risk factors, pathogenesis, signs and symptoms, clinical course, and prognosis.
2. Identify desired therapeutic outcomes for patients with HP-associated ulcers and NSAID-induced ulcers.
3. Identify factors that guide selection of an HP eradication regimen and improve compliance with these regimens.
4. Determine the appropriate management for a patient taking a nonselective NSAID who is at high risk for ulcer-related gastrointestinal complications or who develops an ulcer.
5. Devise an algorithm for evaluation and treatment of a patient with signs and symptoms suggestive of an HP-associated or NSAID-induced ulcer.
6. Given patient-specific information and the prescribed drug treatment regimen, formulate a monitoring plan for a patient who is receiving drug therapy to either eradicate HP or to treat an active NSAID-induced ulcer or gastrointestinal complication.

Faculty:

ACPE No:
014-999-07-028-H04

---

The University of Georgia College of Pharmacy in on probation as an accredited provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. Next scheduled review for purposes of restoring accreditation or removing accredited provider status: June 2009